Human GLP1R Full Length Protein (L260F), Flag,His Tag (Detergent)

ユーザーレビュー
製品番号/仕様
価格
数量
GLR-H52D4-20ug
$805.00
GLR-H52D4-100ug
$2985.00
GLR-H52D4-500ug
$7480.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    GLP-1-R, GLP-1R, glucagon like peptide 1 receptor

  • Source

    Detergent Human GLP1R Full Length Protein (L260F), Flag,His Tag (GLR-H52D4) is expressed from human 293 cells (HEK293). It contains AA Arg 24 - Ser 432 (Accession # P43220-1(L260F)).

    Predicted N-terminus: Asp

  • Molecular Characterization

    GLP1R Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a flag tag at the N-terminus and a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 66.5 kDa.

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Bioactivity-ELISA

     GLP1R ELISA

    Immobilized Human GLP1R Full Length Protein, Flag,His Tag (Cat. No. GLR-H52D4) at 5 μg/mL (100 μL/well) on a Nickel Coated plate (Cat. No. SP-16) can bind Dulaglutide with a linear range of 0.5-16 ng/mL (QC tested).

    Protocol
  •  GLP1R ELISA

    Immobilized Human GLP1R Full Length Protein (L260F), Flag,His Tag (Cat. No. GLR-H52D4) at 5 μg/mL (100 μL/well) can bind Glutazumab with a linear range of 0.06-1 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     GLP1R SPR

    GLP1R agonist captured on Protein A Chip can bind Human GLP1R Full Length Protein, Flag, His Tag (Cat. No. GLR-H52D4) with an affinity constant of 2.74 µM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol
  •  GLP1R SPR

    Monoclonal Anti-GLP1R (Glutazumab) Antibody, Human IgG2 captured on Protein A Chip can bind Human GLP1R Full Length Protein (L260F), Flag,His Tag (Cat. No. GLR-H52D4) with an affinity constant of 43.9 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

The Glucagon-Like Peptide-1 Receptor, a class B GPCR enhancing glucose-dependent insulin secretion and promoting satiety. It is the cornerstone target of blockbuster incretin therapies (semaglutide, tirzepatide) for type 2 diabetes and obesity, with proven cardiovascular and renal protective benefits.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Glucagon-like peptide-1

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    13 詳細

  • 最新の開発ステージ:

    Phase 3 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8